Recent studies demonstrate that the fibroblast growth factor-21 (FGF21), an hepatokine, is partly responsible for the beneficial actions of an exogenously administered NRG1 fusion protein on obesity-related metabolic outcomes [47]. The gene discussed is NRG1; the disease is obesity due to melanocortin 4 receptor deficiency.